Androgenetic Alopecia in Fabry Disease

Completed

Conditions studied: Fabry Disease

In brief

The purpose of this study is to assess whether patients with the classic form of Fabry disease have significantly less androgenic alopecia (male pattern baldness).

Key facts

Study ID

NCT01295008

Run by

Baylor Research Institute

People needed

107

Starts

2010-12-01

Expected to finish

2015-10-01

Last updated by the study team

2016-01-13

Who can join

Age: 18 and older, up to 64. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male patients with Fabry disease age 20-64 years old.
• Healthy male controls age 20-64 years old
• GLA gene mutations associated with the classic form of Fabry disease or having alpha-galactosidase A activity that is essentially zero
• Patients who freely agree to participate in this study and understand the nature, risks and benefits of this study and give their written informed consent.

Where it is running

• Baylor University Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.